Plain-English translation of NCT06124586 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing percutaneous transluminal angioplasty (PTA)—a procedure that opens narrowed or blocked blood vessels in the legs—to see if doing it very quickly after diagnosis helps diabetic foot ulcers heal better. The study compares two groups: one that receives the procedure within 48 hours of being diagnosed with a blocked artery, and another that receives it on the standard schedule within 6 weeks. Both groups receive the same careful monitoring and wound care; only the timing of the procedure differs.
People with type 2 diabetes often develop foot ulcers caused by poor blood flow in their legs. Improving blood flow to the foot is crucial for healing, but doctors are not sure whether doing this procedure immediately—rather than waiting—leads to better outcomes and faster healing.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to one of two groups: one that receives the artery-opening procedure within 48 hours of diagnosis, or one that receives it on the standard schedule within 6 weeks. Both groups will have identical baseline and follow-up visits to monitor how well your foot ulcer is healing, check your overall health, and ensure your kidneys and heart are protected. Throughout the study, specialized medical staff will track your wound healing closely and provide standard diabetic foot care according to medical guidelines.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
Germany